Trial Outcomes & Findings for Is the RAPDx Pupillograph Able to Distinguish Between Glaucoma Subjects and Healthy Subjects? (NCT NCT02526693)

NCT ID: NCT02526693

Last Updated: 2019-10-23

Results Overview

Pupil size changes when light shines into the eyes making the diameter of the pupil smaller (constriction). The size of the pupil's reaction to light, measured in millimeters, is the amplitude or change in diameter. Amplitude of maximum pupil constriction (pupil size) when light is shone is compared between the right and left eyes. Asymmetry is the difference between maximum pupil size of the two eyes.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

104 participants

Primary outcome timeframe

1 examination, one hour

Results posted on

2019-10-23

Participant Flow

Participant milestones

Participant milestones
Measure
Glaucoma Patients
50 Glaucoma patients recruited from Wills Eye Hospital Glaucoma Service will be tested with RAPDx Pupillometer machine. RAPDx Pupillometer: Konan relative afferent pupillary defect RAPDx (Konan Medical USA, Irvine, CA) utilizes digital, high-definition, infrared machine-vision with eye-tracking and automated blink detection technology to analyze and quantify pupillary response to light.
Healthy Controls
50 Healthy subjects with no eye diseases from Wills Eye Hospital Glaucoma Service staff, family and friends will be tested with RAPDx Pupillometer machine. RAPDx Pupillometer: Konan relative afferent pupillary defect RAPDx (Konan Medical USA, Irvine, CA) utilizes digital, high-definition, infrared machine-vision with eye-tracking and automated blink detection technology to analyze and quantify pupillary response to light.
Overall Study
STARTED
53
51
Overall Study
COMPLETED
50
50
Overall Study
NOT COMPLETED
3
1

Reasons for withdrawal

Reasons for withdrawal
Measure
Glaucoma Patients
50 Glaucoma patients recruited from Wills Eye Hospital Glaucoma Service will be tested with RAPDx Pupillometer machine. RAPDx Pupillometer: Konan relative afferent pupillary defect RAPDx (Konan Medical USA, Irvine, CA) utilizes digital, high-definition, infrared machine-vision with eye-tracking and automated blink detection technology to analyze and quantify pupillary response to light.
Healthy Controls
50 Healthy subjects with no eye diseases from Wills Eye Hospital Glaucoma Service staff, family and friends will be tested with RAPDx Pupillometer machine. RAPDx Pupillometer: Konan relative afferent pupillary defect RAPDx (Konan Medical USA, Irvine, CA) utilizes digital, high-definition, infrared machine-vision with eye-tracking and automated blink detection technology to analyze and quantify pupillary response to light.
Overall Study
Physician Decision
3
1

Baseline Characteristics

Is the RAPDx Pupillograph Able to Distinguish Between Glaucoma Subjects and Healthy Subjects?

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Glaucoma
n=50 Participants
Glaucoma patients are recruited from Wills Eye Hospital glaucoma service, who will be tested with the RAPDx Pupillography machine. RAPDx Pupillography: The Konan RAPDx (Konan Medical USA, Irvine, CA) utilizes digital, high-definition, infrared machine-vision with eye-tracking and automated blink detection technology to analyze and quantify the pupillary response to light.
Healthy Control
n=50 Participants
Healthy subjects are recruited from Wills Eye Hospital primary care service, who will be tested with the RAPDx Pupillography machine. RAPDx Pupillography: The Konan RAPDx (Konan Medical USA, Irvine, CA) utilizes digital, high-definition, infrared machine-vision with eye-tracking and automated blink detection technology to analyze and quantify the pupillary response to light.
Total
n=100 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
23 Participants
n=5 Participants
34 Participants
n=7 Participants
57 Participants
n=5 Participants
Age, Categorical
>=65 years
27 Participants
n=5 Participants
16 Participants
n=7 Participants
43 Participants
n=5 Participants
Sex: Female, Male
Female
31 Participants
n=5 Participants
33 Participants
n=7 Participants
64 Participants
n=5 Participants
Sex: Female, Male
Male
19 Participants
n=5 Participants
17 Participants
n=7 Participants
36 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Asian
2 Participants
n=5 Participants
3 Participants
n=7 Participants
5 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
37 Participants
n=5 Participants
14 Participants
n=7 Participants
51 Participants
n=5 Participants
Race (NIH/OMB)
White
9 Participants
n=5 Participants
29 Participants
n=7 Participants
38 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
2 Participants
n=5 Participants
4 Participants
n=7 Participants
6 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Region of Enrollment
United States
50 participants
n=5 Participants
50 participants
n=7 Participants
100 participants
n=5 Participants

PRIMARY outcome

Timeframe: 1 examination, one hour

Pupil size changes when light shines into the eyes making the diameter of the pupil smaller (constriction). The size of the pupil's reaction to light, measured in millimeters, is the amplitude or change in diameter. Amplitude of maximum pupil constriction (pupil size) when light is shone is compared between the right and left eyes. Asymmetry is the difference between maximum pupil size of the two eyes.

Outcome measures

Outcome measures
Measure
Glaucoma Patients
n=50 Participants
Glaucoma patients recruited from Glaucoma Service at Wills Eye Hospital will be tested with RAPDx Pupillography machine Relative afferent pupillary defect RAPDx Pupillography: The Konan RAPDx (Konan Medical USA, Irvine, CA) utilizes digital, high-definition, infrared with eye-tracking and automated blink detection to analyze and quantify pupillary response to light and dark with a standard testing sequence and a custom sequence.
Healthy Controls
n=50 Participants
Healthy subjects are recruited from the Wills Eye clinic, who will be tested with the RAPDx Pupillography machine Relative afferent pupillary defect RAPDx Pupillography: The Konan RAPDx (Konan Medical USA, Irvine, CA) utilizes digital, high-definition, infrared with eye-tracking and automated blink detection to analyze and quantify pupillary response to light and dark with a standard testing sequence and a custom sequence.
Amplitude Asymmetry of Pupil Constriction
Custom sequence
0.8 millimeters
Standard Deviation 0.75
0.29 millimeters
Standard Deviation 0.27
Amplitude Asymmetry of Pupil Constriction
Standard sequence
0.5 millimeters
Standard Deviation 0.52
0.16 millimeters
Standard Deviation 0.12

PRIMARY outcome

Timeframe: 1 examination, one hour

Pupil size changes at different speeds when light shines into the eyes making the diameter of the pupil smaller (constriction). The speed of the pupil's reaction to light is the latency or amount of time. Latency of maximum pupil constriction when light is shone is compared between the right and left eyes. Asymmetry is the difference in time it takes for maximum pupil constriction between the two eyes.

Outcome measures

Outcome measures
Measure
Glaucoma Patients
n=50 Participants
Glaucoma patients recruited from Glaucoma Service at Wills Eye Hospital will be tested with RAPDx Pupillography machine Relative afferent pupillary defect RAPDx Pupillography: The Konan RAPDx (Konan Medical USA, Irvine, CA) utilizes digital, high-definition, infrared with eye-tracking and automated blink detection to analyze and quantify pupillary response to light and dark with a standard testing sequence and a custom sequence.
Healthy Controls
n=50 Participants
Healthy subjects are recruited from the Wills Eye clinic, who will be tested with the RAPDx Pupillography machine Relative afferent pupillary defect RAPDx Pupillography: The Konan RAPDx (Konan Medical USA, Irvine, CA) utilizes digital, high-definition, infrared with eye-tracking and automated blink detection to analyze and quantify pupillary response to light and dark with a standard testing sequence and a custom sequence.
Latency Asymmetry of Pupil Constriction
Custom sequence
0.22 milliseconds
Standard Deviation 0.23
0.14 milliseconds
Standard Deviation 0.14
Latency Asymmetry of Pupil Constriction
Standard sequence
0.2 milliseconds
Standard Deviation 0.21
0.13 milliseconds
Standard Deviation 0.11

PRIMARY outcome

Timeframe: 1 examination, one hour

Log difference between duration of maximum pupil constriction when light is shone into the right versus the left eye. The duration of maximum constriction is calculated as time in milliseconds between point of maximum constriction and time when pupil amplitude has reached 50% of peak amplitude of dilation.

Outcome measures

Outcome measures
Measure
Glaucoma Patients
n=50 Participants
Glaucoma patients recruited from Glaucoma Service at Wills Eye Hospital will be tested with RAPDx Pupillography machine Relative afferent pupillary defect RAPDx Pupillography: The Konan RAPDx (Konan Medical USA, Irvine, CA) utilizes digital, high-definition, infrared with eye-tracking and automated blink detection to analyze and quantify pupillary response to light and dark with a standard testing sequence and a custom sequence.
Healthy Controls
n=50 Participants
Healthy subjects are recruited from the Wills Eye clinic, who will be tested with the RAPDx Pupillography machine Relative afferent pupillary defect RAPDx Pupillography: The Konan RAPDx (Konan Medical USA, Irvine, CA) utilizes digital, high-definition, infrared with eye-tracking and automated blink detection to analyze and quantify pupillary response to light and dark with a standard testing sequence and a custom sequence.
Maximum Constriction Asymmetry Duration
2.23 milliseconds
Standard Deviation 0.64
1.92 milliseconds
Standard Deviation 0.54

Adverse Events

Glaucoma Patients

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Healthy Controls

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

George L. Spaeth, MD

Wills Eye Hospital

Phone: 215-928-3123

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place